Recombinant PKC alpha anticorps

N° du produit ABIN7799989

Cet anticorps anti-PKC alpha est un anticorps Lapin Monoclonal détectant PKC alpha dans WB, ICC, FACS et IF (p). Adapté pour Humain.

Aperçu rapide pour Recombinant PKC alpha anticorps (ABIN7799989)

Antigène: PKC alpha (PKCa) (Protein Kinase C, alpha (PKCa))

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Lapin

Clonalité: Monoclonal

Conjugué: Cet anticorp PKC alpha est non-conjugé

Application: Western Blotting (WB), Immunocytochemistry (ICC), Flow Cytometry (FACS), Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Classe de qualité: KD Validated

Clone: 23GB1690

Détail du produit anti-PKC alpha anticorps

Expression System: HEK-293 Cells

Fonction: KD-Validated PKC alpha Recombinant Rabbit mAb

Réactivité croisée: Souris, Rat

Purification: Affinity Purified

Immunogène: A synthesized peptide derived from human PKC alpha

Isotype: IgG

Information d'application

Indications d'application: Western Blotting (WB): 1:1,000-1:5,000, Flow Cytometry (FCM): 1:200-1:2,000, Immunocytochemistry (ICC): 1:100-1:1,000, Immunohistochemistry-Paraffin (IHC-P): 1:100-1:200

Commentaires:

We assess the antibodies’ specificity and selectivity using knockdown techniques. Our validation approach is straightforward: if an antibody identifies a signal in wild-type (WT) cells, but this signal is absent or noticeably reduced in gene-silenced (KD) cells, we consider the antibody to be highly specific.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: PBS, pH 7.4, with 0.02 % sodium azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20 °C for one year.

Date de péremption: 12 months

Détails sur PKC alpha

Antigène: PKC alpha (PKCa) (Protein Kinase C, alpha (PKCa))

Autre désignation: PKC alpha

Poids moléculaire: 77 kDa

ID gène: 5578

UniProt: P17252

Pathways: Signalisation WNT, TCR Signaling, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Thyroid Hormone Synthesis, cAMP Metabolic Process, Myometrial Relaxation and Contraction, Cell-Cell Junction Organization, Regulation of G-Protein Coupled Receptor Protein Signaling, G-protein mediated Events, Signaling Events mediated by VEGFR1 and VEGFR2, Interaction of EGFR with phospholipase C-gamma, Thromboxane A2 Receptor Signaling, VEGFR1 Specific Signals, VEGF Signaling